Kallyope is a Biotech company based in New York, NY. It has raised $487M in total funding. Latest round: Grant.
Kallyope funding overview
Kallyope is a Biotech company based in New York, NY. Kallyope has raised $487M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Grant announced in May 2023. The round record for Kallyope runs through 2023; nothing later has been disclosed. Investors on record include Mubadala Investment Company, The Column Group, Lux Capital, Two Sigma Ventures. 4 distinct backers are named across the disclosed rounds.
Kallyope at a glance
Total raised
$487M
Latest round
Grant
Latest round date
May 2023
Industry
Biotech
Headquarters
New York, NY
Notable investors
Mubadala Investment Company, The Column Group, Lux Capital, Two Sigma Ventures
Frequently asked about Kallyope funding
How much has Kallyope raised?
Kallyope has raised $487M in total disclosed funding across the rounds on record.
Who has invested in Kallyope?
Mubadala Investment Company, The Column Group, Lux Capital, Two Sigma Ventures are named among the investors backing Kallyope.
What was the latest Kallyope funding round?
The most recent disclosed round is a Grant, announced in May 2023.
Where is Kallyope based?
Kallyope is based in New York, NY.
What sector does Kallyope operate in?
Kallyope is tracked under Biotech from New York, NY, with $487M in disclosed funding.
When did Kallyope last raise?
The last disclosed Kallyope round closed in May 2023 at Grant.
Every Kallyope figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in New York at a similar stage.
